Clinical Trial Update: Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LP-98 Injection in Healthy Subjects [Phase 1]

View source ↗

Summary

This Phase 1 study updates on the safety, tolerability, pharmacokinetics, and immunogenicity of LP-98 Injection in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• LP-98 Injection

Snippet

Sponsor: Shanxi Kangbao Biological Product Co., Ltd. | Conditions: Hiv | Phase 1 | Status: COMPLETED